LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 72.52 | 84.90 | 3496 | 9214 | 0.3794 | 0.7330 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 72.52 | 84.90 | 1096 | 9214 | 0.1189 | 0.4598 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 72.52 | 84.90 | 3731 | 9214 | 0.4049 | 0.7497 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 74.22 | 84.90 | 189 | 9343 | 0.0202 | 0.1253 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 74.22 | 84.90 | 3547 | 9343 | 0.3796 | 0.7338 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 74.22 | 84.90 | 658 | 9343 | 0.0704 | 0.3525 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 74.22 | 84.90 | 3772 | 9343 | 0.4037 | 0.7496 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 75.93 | 84.90 | 203 | 8970 | 0.0226 | 0.1384 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 75.93 | 84.90 | 3657 | 8970 | 0.4077 | 0.7501 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 75.93 | 84.90 | 369 | 8970 | 0.0411 | 0.2443 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 75.93 | 84.90 | 3855 | 8970 | 0.4297 | 0.7639 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 77.64 | 84.90 | 208 | 9245 | 0.0225 | 0.1416 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 77.64 | 84.90 | 3708 | 9245 | 0.4011 | 0.7474 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 77.64 | 84.90 | 88 | 9245 | 0.0095 | 0.0053 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 77.64 | 84.90 | 3919 | 9245 | 0.4239 | 0.7618 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 79.34 | 84.90 | 176 | 9051 | 0.0194 | 0.1143 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 79.34 | 84.90 | 3805 | 9051 | 0.4204 | 0.7586 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 79.34 | 84.90 | 48 | 9051 | 0.0053 | -0.0812 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 79.34 | 84.90 | 3941 | 9051 | 0.4354 | 0.7678 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 81.05 | 84.90 | 164 | 8863 | 0.0185 | 0.1032 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 81.05 | 84.90 | 3865 | 8863 | 0.4360 | 0.7672 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 81.05 | 84.90 | 39 | 8863 | 0.0044 | -0.1095 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 81.05 | 84.90 | 3948 | 8863 | 0.4454 | 0.7728 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.75 | 84.90 | 132 | 8621 | 0.0153 | 0.0685 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.75 | 84.90 | 3930 | 8621 | 0.4558 | 0.7777 | MN20160318_Q02 | C22 |